Connection

Marco Guazzi to Phosphodiesterase 5 Inhibitors

This is a "connection" page, showing publications Marco Guazzi has written about Phosphodiesterase 5 Inhibitors.
Connection Strength

0.263
  1. Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation. Eur J Heart Fail. 2017 05; 19(5):691.
    View in: PubMed
    Score: 0.155
  2. Phosphodiesterase-5 inhibition mimics intermittent reoxygenation and improves cardioprotection in the hypoxic myocardium. PLoS One. 2011; 6(11):e27910.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.